USFDA issues warning letter to Indoco Remedies’ Goa plantPost published:April 12, 2017Post category:Industry NewsUSFDA inspectors found significant violations of manufacturing practice regulations for finished pharmaceuticals at Indoco Remedies after inspecting it last year Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostCarlsberg India launches new beer Tuborg Classic Next PostApple’s Make in India tax demands rejected due to GST, says minister You Might Also Like EVT announces EyeVision support for Intel Real Sense D-400 January 8, 2018 Google not interested in becoming a financial provider: Diana Layfield September 20, 2017 Inventory Management 4.0 January 4, 2019